Skip to main content

Advertisement

SpringerLink
Log in

Recent alternative approaches of vascular drug-eluting stents

  • Review
  • Published:
Journal of Pharmaceutical Investigation Aims and scope Submit manuscript

Abstract

Vascular stent is tubular shaped medical device designed to treat occluded circulatory or digestive systems by opening the blocked vascular sites. Originally stents were made of bare metals, such as stainless steel and cobalt–chromium alloys, due to their inherent corrosion resistance and good mechanical properties. Damage of intimal layer during expansion of stent, however, have caused neointimal hyperplasia resulting in in-stent restenosis which is one of main complications of vascular stent treatment. Drug-eluting stents (DESs) were introduced to alleviate this restenosis by local delivery of anti-proliferative drugs to the implanted or inserted site. The DES systems have been developed over the years by making changes in its main component, namely, drug, polymeric coating layer and expandable scaffold. Nevertheless, late thrombosis caused by drugs themselves and polymeric coating layer still remains as a serious problem of DES systems. Numerous studies, therefore, consistently focus on more advanced DES systems to solve the current issues. In this mini review article, we cast an opinion on how to improve the potential of DES system by means of (i) summarizing the history of DES system developed so far and (ii) updating current advances for the future generation of DES system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Reprinted with permission from BMJ Publishing Group

Fig. 2
Fig. 3

Reprinted with permission from RSC Publishing, Elsevier, and John Wiley and Sons

Similar content being viewed by others

References

  • Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ (2004) Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110:3300–3305

    PubMed  Google Scholar 

  • Abizaid A, Costa JR (2010) New drug-eluting stents. An overview on biodegradable and polymer-free next-generation stent systems. Circ Cardiovasc Interv 3:384–393

    CAS  PubMed  Google Scholar 

  • Acharya G, Park K (2006) Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev 58:387–401

    CAS  PubMed  Google Scholar 

  • Akin I, Schneider H, Ince H, Kische S, Rehders TC, Chatterjee T, Nienaber CA (2011) Second- and third-generation drug-eluting coronary stents: progress and safety. Herz 36:190–196

    CAS  PubMed  Google Scholar 

  • Anderson JM (2001) Biological responses to materials. Annu Rev Mater Res 31:81–110

    CAS  Google Scholar 

  • Andukuri A, Min I, Hwang P, Alexander G, Marshall LE, Berry JL, Wick TM et al (2014) Evaluation of the effect of expansion and shear stress on a self-assembled endothelium mimicking nanomatrix coating for drug eluting stents in vitro and in vivo. Biofabrication 6:035019

    PubMed  PubMed Central  Google Scholar 

  • Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–966

    CAS  PubMed  Google Scholar 

  • Awada HK, Johnson NR, Wang Y (2014) Dual delivery of vascular endothelial growth factor and hepatocyte growth factor coacervate displays strong angiogenic effects. Macromol Biosci 14:679–686

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bedair TM, Cho Y, Joung YK, Han DK (2014) Biodegradable polymer brush as nanocoupled interface for improving the durability of polymer coating on metal surface. Coll Surf B Biointerfaces 122:808–817

    CAS  Google Scholar 

  • Beijk MAM, Klomp M, Verouden NJW, van Geloven N, Koch KT, Henriques JPS, Baan J et al (2010) Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study. Eur Heart J 31:1055–1064

    PubMed  Google Scholar 

  • Bhatia V, Bhatia R, Dhindsa M (2004) Drug-eluting stents: new era and new concerns. Postgrad Med J 80:13–18

    CAS  PubMed  PubMed Central  Google Scholar 

  • Böstman O, Pihlajamäki H (2000) Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review. Biomaterials 21:2615–2621

    PubMed  Google Scholar 

  • Bridges J, Cutlip D (2009) Advances in drug eluting stents – focus on the Endeavor® zotarolimus stent. Med Devices (Auckl) 2:1–8

    CAS  Google Scholar 

  • Busch R, Strohbach A, Rethfeldt S, Walz S, Busch M, Petersen S, Felix S et al (2014) New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets. Acta Biomater 10:688–700

    CAS  PubMed  Google Scholar 

  • Che HL, Bae IH, Lim KS, Song IT, Lee H, Muthiah M, Namgung R et al (2012) Suppression of post-angioplasty restenosis with an Akt1 siRNA-embedded coronary stent in a rabbit model. Biomaterials 33:8548–8556

    CAS  PubMed  Google Scholar 

  • Chen HW, Huang HC (1998) Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br J Pharmacol 124:1029–1040

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chen MC, Liu CT, Tsai HW, Lai WY, Chang Y, Sung HW (2009) Mechanical properties, drug eluting characteristics and in vivo performance of a genipin-crosslinked chitosan polymeric stent. Biomaterials 30:5560–5571

    CAS  PubMed  Google Scholar 

  • Chen W, Habraken TC, Hennink WE, Kok RJ (2015) Polymer-free drug-eluting stents: an overview of coating strategies and comparison with polymer-coated drug-eluting stents. Bioconjug Chem 26:1277–1288

    CAS  PubMed  Google Scholar 

  • Chevalier B, Wijns W, Silber S, Garcia E, Serra A, Paunovic D, Serruys P (2015) Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial. EuroIntervention 11:549–554

    PubMed  Google Scholar 

  • Choi J, Cho SB, Lee BS, Joung YK, Park K, Han DK (2011) Improvement of interfacial adhesion of biodegradable polymers coated on metal surface by nanocoupling. Langmuir 27:14232–14239

    CAS  PubMed  Google Scholar 

  • Choi DH, Kang SN, Kim SM, Gobaa S, Park BJ, Kim IH, Joung YK et al (2016) Growth factors-loaded stents modified with hyaluronic acid and heparin for induction of rapid and tight re-endothelialization. Coll Surf B Biointerfaces 141:602–610

    CAS  Google Scholar 

  • Clowes AW, Karnowsky MJ (1977) Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 265:625–626

    CAS  PubMed  Google Scholar 

  • Collet C, Sotomi Y, Cavalcante R, Suwannasom P, Tenekecioglu E, Onuma Y, Serruys PW (2016) Coronary stent thrombosis: what have we learned? J Thorac Dis 8:1398–1405

    PubMed  PubMed Central  Google Scholar 

  • Cui S, Liu JH, Song XT, Ma GL, Du BJ, Lv SZ, Meng LJ et al (2014) A novel stent coated with antibodies to endoglin inhibits neointimal formation of porcine coronary arteries. BioMed Res Int 2014:428619

    PubMed  PubMed Central  Google Scholar 

  • Dong C, Song D, Cairney J, Maddan OL, He G, Deng Y (2011) Antibacterial study of Mg(OH)2 nanoplatelets. Mater Res Bull 46:576–582

    CAS  Google Scholar 

  • Dunne M, Corrigan OI, Ramtoola Z (2000) Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials 21:1659–1668

    CAS  PubMed  Google Scholar 

  • Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, Litt MR et al (2015) Everolimus-eluting bioresorbable scaffolds for coronary artery disease. N Engl J Med 373:1905–1915

    CAS  PubMed  Google Scholar 

  • Elnaggar MA, Seo SH, Gobaa S, Lim KS, Bae I-H, Jeong MH, Han DK et al (2016) Nitric oxide releasing coronary stent: a new approach using layer-by-layer coating and liposomal encapsulation. Small 12:6012–6023

    CAS  PubMed  Google Scholar 

  • Ernst A, Bulum J (2014) New generations of drug-eluting stents-A brief review. EMJ Int Cardiol 1:100–106

    Google Scholar 

  • Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K et al (2005) Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112:270–278

    CAS  PubMed  Google Scholar 

  • Fishbein I, Chorny M, Adamo RF, Forbes SP, Corrales RA, Alferiev IS, Levy RJ (2013) Endovascular gene delivery from a stent platform: gene- eluting stents. Angiol Open Access. https://doi.org/10.4172/2329-9495.1000109

    Article  PubMed  PubMed Central  Google Scholar 

  • Gallo A, Mani G (2013) A stent for co-delivering paclitaxel and nitric oxide from abluminal and luminal surfaces: preparation, surface characterization, and in vitro drug release studies. Appl Surf Sci 279:216–232

    CAS  Google Scholar 

  • Garg S, Serruys PW (2010) Coronary stents: looking forward. J Am Coll Cardiol 56:S43-S78

    Google Scholar 

  • Grabow N, Martin DP, Schmitz K-P, Sternberg K (2010) Absorbable polymer stent technologies for vascular regeneration. J Chem Tech Biotechnol 85:744–751

    CAS  Google Scholar 

  • Hammond PT (2010) Thin films: particles release. Nat Mater 9:292–293

    CAS  PubMed  Google Scholar 

  • Harada M, Takenaka H, Ikenaga S, Zhang H, Zempo N, Esato K, Nagano T et al (2002) Hepatocyte growth factor prevents intimal hyperplasia in rabbit carotid expanded polytetrafluoroethylene grafting. J Vasc Surg 35:786–791

    PubMed  Google Scholar 

  • Haude M, Erbel R, Issa H, Meyer J (1993) Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents. J Am Coll Cardiol 21:26–34

    CAS  PubMed  Google Scholar 

  • Hedin M (1997) The origin of the word stent. Acta Radiol 38:937–939

    CAS  PubMed  Google Scholar 

  • Hezi-Yamit A, Sullivan C, Wong J, David L, Chen M, Cheng P, Shumaker D et al (2008) Impact of polymer hydrophilicity on biocompatibility: implication for DES polymer design. J Biomed Mater Res A 90:133–141

    Google Scholar 

  • Huang SL, Kee PH, Kim H, Moody MR, Chrzanowski SM, MacDonald RC, McPherson DD (2009) Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia. J Am Coll Cardiol 54:652–659

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hwang CW, Levin AD, Jonas M, Li PH, Edelman ER (2005) Thrombosis modulates arterial drug distribution for drug-eluting stents. Circulation 111:1619–1626

    CAS  PubMed  Google Scholar 

  • Jin X, Mei L, Song C, Liu L, Leng X, Sun H, Kong D et al (2008) Immobilization of plasmid DNA on an anti-DNA antibody modified coronary stent for intravascular site-specific gene therapy. J Gene Med 10:421–429

    CAS  PubMed  Google Scholar 

  • Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R et al (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193–202

    PubMed  Google Scholar 

  • Jorge C, Dubois C (2015) Clinical utility of platinum chromium bare-metal stents in coronary heart disease. Med Devices (Auckl) 8:359–367

    CAS  Google Scholar 

  • Kadota K, Muramatsu T, Iwabuchi M, Saito S, Hayashi Y, Ikari Y, Nanto S et al (2012) Randomized comparison of the Nobori Biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries. Catheter Cardiovasc Interv 80:789–796

    PubMed  Google Scholar 

  • Kang SN, Park C, Kim SM, Park KW, Park BJ, Han DK, Joung YK (2015) Effect of stromal cell derived factor-1α release from heparin-coated Co-Cr stent substrate on the recruitment of endothelial progenitor cells. Macromol Res 23:1159–1167

    CAS  Google Scholar 

  • Kim SM, Park KS, Lih E, Hong YJ, Kang JH, Kim IH, Jeong MH et al (2016) Fabrication and characteristics of dual functionalized vascular stent by spatio-temporal coating. Acta Biomater 38:143–152

    CAS  PubMed  Google Scholar 

  • Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC, Pratt RE et al (2004a) Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 110:2039–2046

    CAS  PubMed  Google Scholar 

  • Kong D, Melo LG, Mangi AA, Zhang L, Lopez-Ilasaca M, Perrella MA, Liew CC et al (2004b) Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 109:1769–1775

    CAS  PubMed  Google Scholar 

  • Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB (1998) In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 31:224–230

    CAS  PubMed  Google Scholar 

  • Kum CH, Cho Y, Joung YK, Choi J, Park K, Seo SH, Park YS et al (2013) Biodegradable poly(l-lactide) composites by oligolactide-grafted magnesium hydroxide for mechanical reinforcement and reduced inflammation. J Mater Chem B 1:2764–2772

    CAS  Google Scholar 

  • Kum CH, Seo SH, Kang SN, Park BJ, Ahn DJ, Joung YK, Han DK (2014a) Effect of magnesium hydroxide nanoparticles with rod and plate shape on mechanical and biological properties of poly(L-lactide) composites. Macromol Res 22:1032–1041

    CAS  Google Scholar 

  • Kum CH, Cho Y, Seo SH, Joung YK, Ahn DJ, Han DK (2014b) A poly(lactide) stereocomplex structure with modified magnesium oxide and its effects in enhancing the mechanical properties and suppressing inflammation. Small 10:3783–3794

    CAS  PubMed  Google Scholar 

  • Lau TT, Wang DA (2011) Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine. Expert Opin Biol Ther 11:189–197

    CAS  PubMed  Google Scholar 

  • Lee SW, Lam SC, Tam FC, Chan KK, Shea CP, Kong SL, Wong AY et al (2016) Evaluation of early healing profile and neointimal transformation over 24 months using longitudinal sequential optical coherence tomography assessments and 3-year clinical results of the new dual-therapy endothelial progenitor cell capturing sirolimus-eluting combo stent: the EGO-Combo study. Circ Cardiovasc Interv. https://doi.org/10.1161/CIRCINTERVENTIONS.115.003469

    Article  PubMed  PubMed Central  Google Scholar 

  • Levy Y, Tal N, Tzemach G, Weinberger J, Domb AJ, Mandler D (2009) Drug-eluting stent with improved durability and controllability properties, obtained via electrocoated adhesive promotion layer. J Biomed Mater Res B Appl Biomater 91:819–830

    PubMed  Google Scholar 

  • Lim WH, Seo WW, Choe W, Kang CK, Park J, Cho HJ, Kyeong S et al (2011) Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation. Arterioscler Thrombo Vasc Biol 31:2798–2805

    CAS  Google Scholar 

  • Lim KS, Park JK, Jeong MH, Bae IH, Nah JW, Park DS, Sim JW et al (2016) Optimal coating method for a dual-layer stent with sirolimus and alpha-lipoic acid in a porcine coronary restenosis model. Macromol Res 24:725–733

    CAS  Google Scholar 

  • Liu H, Slamovich EB, Webster TJ (2006) Less harmful acidic degradation of poly(lactic-co-glycolic acid) bone tissue engineering scaffolds through titania nanoparticle addition. Int J Nanomed 1:541–545

    CAS  Google Scholar 

  • Malam Y, Loizidou M, Seifalian AM (2009) Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 30:592–599

    CAS  PubMed  Google Scholar 

  • Mani G, Feldman MD, Patel D, Agrawal CM (2007) Coronary stents: a materials perspective. Biomaterials 28:1689–1710

    CAS  PubMed  Google Scholar 

  • Marketou ME, Kalyva A, Parthenakis FI, Pontikoglou C, Maragkoudakis S, Kontaraki JE, Chlouverakis G et al (2014) Circulating endothelial progenitor cells in hypertensive patients with increased arterial stiffness. J Clin Hypertens 16:295–300

    CAS  Google Scholar 

  • Meraj PM, Jauhar R, Singh A (2015) Bare metal stents versus drug eluting stents: where do we stand in 2015? Curr Treat Options Cardiovasc Med 17:393

    PubMed  Google Scholar 

  • Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP et al (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–1323

    CAS  PubMed  Google Scholar 

  • Naghavi N, de Mel A, Alavijeh OS, Cousins BG, Seifalian AM (2013) Nitric oxide donors for cardiovascular implant applications. Small 9:22–35

    CAS  PubMed  Google Scholar 

  • Naldini L (2015) Gene therapy returns to centre stage. Nature 526:351–360

    CAS  PubMed  Google Scholar 

  • Nam SH, Nam HY, Joo JR, Back IS, Park JS (2007) Curcumin-loaded PLGA nanoparticles coating onto metal stent by electrophoretic deposition techniques. Bull Korean Chem Soc 28:397–402

    CAS  Google Scholar 

  • Natsuaki M, Kozuma K, Morimoto T, Kadota K, Muramatsu T, Nakagawa Y, Akasaka T et al (2015) Final 3-year outcome of a randomized trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer. NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent trial. Circ Cardiovasc Interv. https://doi.org/10.1161/CIRCINTERVENTIONS.115.002817

    Article  PubMed  Google Scholar 

  • Ohtani K, Egashira K, Nakano K, Zhao G, Funakoshi K, Ihara Y, Kimura S et al (2006) Stent-based local delivery of nuclear factor-κB decoy attenuates in-stent restenosis in hypercholesterolemic rabbits. Circulation 114:2773–2779

    CAS  PubMed  Google Scholar 

  • Pan CJ, Tang JJ, Shao ZY, Wang J, Huang N (2007) Improved blood compatibility of rapamycin-eluting stent by incorporating curcumin. Coll Surf B Biointerfaces 59:105–111

    CAS  PubMed  Google Scholar 

  • Park DW, Park SW, Park KH, Lee BK, Kim YH, Lee CW, Hong MK et al (2006) Frequency of and Risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 98:352–356

    PubMed  Google Scholar 

  • Park C, Kim S, Kim HE, Jang TS (2016) Mechanically stable tantalum coating on a nano-roughened NiTi stent for enhanced radiopacity and biocompatibility. Surf Coat Technol 305:139–145

    CAS  Google Scholar 

  • Poh CK, Shi Z, Lim TY, Neoh KG, Wang W (2010) The effect of VEGF functionalization of titanium on endothelial cells in vitro. Biomaterials 31:1578–1585

    CAS  PubMed  Google Scholar 

  • Polyak B, Medved M, Lazareva N, Steele L, Patel T, Rai A, Rotenberg MY et al (2016) Magnetic nanoparticle-mediated targeting of cell therapy reduces in-stent stenosis in injured arteries. ACS Nano 10:9559–9569

    CAS  Google Scholar 

  • Porta-i-Batalla M, Eckstein C, Xifré-Pérez E, Formentín P, Ferré-Borrull J, Marsal LF (2016) Sustained, controlled and stimuli-responsive drug release systems based on nanoporous anodic alumina with layer-by layer polyelectrolyte recent developments in drug eluting devices with tailored interfacial properties. Nanoscale Res Lett. https://doi.org/10.1186/s11671-016-1585-4

    Article  PubMed  PubMed Central  Google Scholar 

  • Puranik AS, Dawson ER, Peppas NA (2013) Recent advances in drug eluting stents. Int J Pharm 441:665–679

    CAS  PubMed  Google Scholar 

  • Rensing BJ, Vos J, Smits PC, Foley DP, van den Brand MJ, van der Giessen WJ, de Feijter PJ et al (2001) Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J 22:2125–2130

    CAS  PubMed  Google Scholar 

  • Rios HF, Lin Z, Oh B, Park CH, Giannobile WV (2011) Cell- and gene-based therapeutic strategies for periodontal regenerative medicine. J Periodontol 82:1223–1237

    CAS  PubMed  PubMed Central  Google Scholar 

  • Saris NEL, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A (2000) Magnesium: an update on physiological, clinical and analytical aspects. Clin Chim Acta 294:1–26

    CAS  PubMed  Google Scholar 

  • Sedaghat A, Sinning JM, Paul K, Kirfel G, Nickenig G, Werner N (2013) First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model. Clin Res Cardiol 102:413–425

    CAS  PubMed  Google Scholar 

  • Sethi R, Lee CH (2012) Endothelial progenitor cell capture stent: safety and effectiveness. J Interv Cardiol 25:493–500

    PubMed  Google Scholar 

  • Shah BH, Nawaz Z, Pertani SA, Roomi A, Mahmood H, Saeed SA, Gilani AH (1999) Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochem Pharmacol 58:1167–1172

    CAS  PubMed  Google Scholar 

  • Shaikh M, Kichenadasse G, Choudhury NR, Butler R, Garg S (2013) Non-vascular drug eluting stents as localized controlled drug delivery platform: preclinical and clinical experience. J Control Release 172:105–117

    CAS  PubMed  Google Scholar 

  • Sharif F, Hynes SO, McCullagh KJA, Ganley S, Greiser U, McHugh P, Crowley J et al (2012) Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model. Gene Ther 19:321–328

    CAS  PubMed  Google Scholar 

  • Shaulov Y, Okner R, Levi Y, Tal N, Gutkin V, Mandler D, Domb AJ (2009) Poly(methyl methacrylate) grafting onto stainless steel surfaces: application to drug-eluting stents. ACS Appl Mater Interfaces 1:2519–2528

    CAS  PubMed  Google Scholar 

  • Sorrentino S, Giustino G, Mehran R, Kini AS, Sharma SK, Faggioni M, Farhan S et al (2017) Everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents. J Am Coll Cardiol 69:3055–3066

    CAS  PubMed  Google Scholar 

  • Stefanini GG, Holmes DRJ (2013) Drug-eluting coronary-artery stents. N Engl J Med 368:254–265

    CAS  PubMed  Google Scholar 

  • Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M et al (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221–231

    CAS  PubMed  Google Scholar 

  • Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A et al (2007) Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356:998–1008

    CAS  PubMed  Google Scholar 

  • Su LC, Chen YH, Chen MC (2013) Dual drug-eluting stents coated with multilayers of hydrophobic heparin and sirolimus. ACS Appl Mater Interfaces 5:12944–12953

    CAS  PubMed  Google Scholar 

  • Sung HJ, Meredith C, Johnson C, Galis ZS (2004) The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 25:5735–5742

    CAS  PubMed  Google Scholar 

  • Tebas P, Stein D, Tang WW, Frank I, Wang SQ, Lee G, Spratt SK et al (2014) Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 370:901–910

    CAS  PubMed  PubMed Central  Google Scholar 

  • ten Berg JM, Plokker HWT, Verheugt FWA (2001) Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention. Curr Control Trials Cardiovasc Med 2:129–140

    PubMed  PubMed Central  Google Scholar 

  • Thierry B, Winnik FM, Merhi Y, Silver J, Tabrizian M (2003) Bioactive coatings of endovascular stents based on polyelectrolyte multilayers. Biomacromol 4:1564–1571

    CAS  Google Scholar 

  • Tsuji H, Ikada Y (1999) Stereocomplex formation between enantiomeric poly(lactic acid)s. XI. Mechanical properties and morphology of solution-cast films. Polymer 40:6699–6708

    CAS  Google Scholar 

  • van Beusekom HMM, Ertaş G, Sorop O, Serruys PW, van der Giessen WJ (2012) The genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries. Catheter Cardiovasc Interv 79:231–242

    PubMed  Google Scholar 

  • Vara JÁF, Casado E, de Castro J, Cejas P, Belda-Iniesta C, González-Barón M (2004) PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30:193–204

    CAS  Google Scholar 

  • Virmani R, Liistro F, Stankovic G, Di Mario C, Montorfano M, Farb A, Kolodgie FD et al (2002) Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate–eluting polymer stent system in humans. Circulation 106:2649–2651

    CAS  PubMed  Google Scholar 

  • Voinea M, Simionescu M (2002) Designing of ‘intelligent’ liposomes for efficient delivery of drugs. J Cell Molecular Med 6:465–474

    CAS  Google Scholar 

  • Walter DH, Cejna M, Diaz-Sandoval L, Willis S, Kirkwood L, Stratford PW, Tietz AB et al (2004) Local gene transfer of phVEGF-2 plasmid by gene-eluting stents. Alt Strategy Inh Restenosis Circ 110:36–45

    CAS  Google Scholar 

  • Welt FGP, Rogers C (2002) Inflammation and restenosis in the stent era. Arterioscler Thromb VAsc Biol 22:1769–1776

    CAS  PubMed  Google Scholar 

  • Werner N, Junk S, Laufs U, Link A, Walenta K, Böhm M, Nickenig G (2003) Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circulation Res 93:e17–e24

    CAS  PubMed  Google Scholar 

  • Wiemer M, Stoikovic S, Samol A, Dimitriadis Z, Ruiz-Nodar JM, Birkemeyer R, Monsegu J et al (2017) Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up. Cardiovasc Diabetol 16:23. https://doi.org/10.1186/s12933-017-0500-3

    Article  PubMed  PubMed Central  Google Scholar 

  • Wilson GJ, Nakazawa G, Schwartz RS, Huibregtse B, Poff B, Herbst TJ, Baim DS et al (2009) Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation 120:141–149

    CAS  PubMed  Google Scholar 

  • Zhang Y, Bourantas CV, Farooq V, Muramatsu T, Diletti R, Onuma Y, Garcia-Garcia HM et al (2013) Bioresorbable scaffolds in the treatment of coronary artery disease. Med Devices (Auckl) 6:37–48

    Google Scholar 

Download references

Acknowledgements

This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by Ministry of Science and ICT (NRF-2014M3A9D3033887 and NRF-2015M3A9E2028580), and Strategic Core Materials Technology Development Program (10062079) funded by Ministry of Trade Industry and Energy (MOTIE), Republic of Korea.

Disclosure

Cheol-Min Han, Kwang-Sook Park and Yoon Ki Joung declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Center for Biomaterials, Korea Institute of Science and Technology, Seoul, 02792, South Korea

    Cheol-Min Han, Kwang-Sook Park & Yoon Ki Joung

  2. Division of Bio-Medical Science and Technology, University of Science and Technology (UST), Daejeon, 34113, South Korea

    Yoon Ki Joung

Authors
  1. Cheol-Min Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kwang-Sook Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoon Ki Joung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoon Ki Joung.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Han, CM., Park, KS. & Joung, Y.K. Recent alternative approaches of vascular drug-eluting stents. Journal of Pharmaceutical Investigation 48, 153–165 (2018). https://doi.org/10.1007/s40005-017-0378-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40005-017-0378-9

Keywords

Search

Navigation